NCM · Medical - Diagnostics & Research
Advanced Biomed Inc. (ADVB) Stock
$5.31
-13.24%
NCM: ADVB
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held73.92%
Institutions Held0.00%
Institutions Float Held0.00%
Peer Comparison
About Advanced Biomed Inc.
Advanced Biomed Inc. is led by CEO Yi Lu, employs 40 people, headquartered in US, publicly traded since 2025.
Advanced Biomed Inc. (ADVB) stock trades at $5.31 with a market capitalization of $7.34M. The stock is valued at a price-to-earnings (P/E) ratio of -29.77, price-to-book of 0.88, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.61 and $24.23, and currently trades 78.1% below its 52-week high.
On profitability, Advanced Biomed Inc. generates a return on equity (ROE) of -20.71%, return on capital employed of -11.88%, an operating margin of 0.00%, a net profit margin of 0.00%.